Overexpression of Forkhead box M1 protein associates with aggressive tumor features and poor prognosis of hepatocellular carcinoma

Oncology Reports

Volumn 25, Issue 6, 2011, Pages 1533-1539

  Sun, Hong Cheng ^a   Li, Min ^a   Lu, Ji Lin ^a   Yan, Dong Wang ^a   Zhou, Chong Zhi ^a   Fan, Jun Wei ^a   Qin, Xue Bin ^b   Tang, Hua Mei ^a   Peng, Zhi Hai ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Forkhead box M1; Hepatocellular carcinoma; Prognosis; Tissue microarray

Indexed keywords

CYCLINE; FORKHEAD BOX M1 PROTEIN; FORKHEAD TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ADULT; ADVANCED CANCER; ARTICLE; CANCER GROWTH; CANCER INVASION; CANCER PATIENT; CANCER RECURRENCE; CANCER SIZE; CANCER STAGING; CANCER SURVIVAL; CELL DIFFERENTIATION; CELL PROLIFERATION; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ACTIVITY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; LIVER CELL CARCINOMA; LIVER RESECTION; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PHENOTYPE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; TISSUE SECTION; TUMOR VASCULARIZATION;

CARCINOMA, HEPATOCELLULAR; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; IMMUNOHISTOCHEMISTRY; LIVER NEOPLASMS; MALE; MIDDLE AGED; PROGNOSIS; TISSUE ARRAY ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 79954518901     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2011.1230     Document Type: Article

References (26)

1. Llovet JM, Burroughs A and Bruix J: Hepatocellular carcinoma Lancet 362: 1907-1917, 2003.
2. EI-Serag HB, Davila JA, Petersen NJ and McGlynn KA: The continuing increase in the incidence of hepatocellular carcinoma in the United States: an update. Ann Intern Med 139: 817-823, 2003.
3. Chen XP, Qiu FZ, Wu ZD, Zhang ZW, Huang ZY and Chen YF: Long-term outcome of resection of large hepatocellular carcinoma Br J Surg 93: 600-606, 2006.
4. Mann CD, Neal CP, Garcea G, Manson MM, Dennison AR and Berry DP: Prognostic molecular markers in hepatocellular carcinoma: a systematic review. Eur J Cancer 43: 979-992, 2007. (Pubitemid 46483030)
5. Frau M, Biasi F, Feo F and Pascale RM: Prognostic markers and putative therapeutic targets for hepatocellular carcinoma. Mol Aspects Med 31: 179-193, 2010.
6. Kalinichenko W, Major ML, Wang X, et al: Foxm1b transcription factor is essential for development of hepatocellular carcinoma and is negatively regulated by the p19ARF tumor suppressor. Genes Dev 18: 830-850, 2004. (Pubitemid 38480894)
7. Gusarova GA, Wang IC, Major ML, et al: A cell-penetrating ARF peptide inhibitor of FoxM1 in mouse hepatocellular carcinoma treatment. J Clin Invest 117: 99-111, 2007. (Pubitemid 46048457)
8. Wu QF, Liu C, Tai MH, et al: Knockdown of Fox1M1 si RNA interference decreases cell proliferation, induces cell cycle arrest and inhibits cell invasion in MHCC-97H cells in vitro. Acta Pharmacol Sin 31: 361-366, 2010.
9. Wierstra I and Alves J: FOXM1, a typical proliferation-associated transcription factor. Biol Chem 388: 1257-1274, 2007. (Pubitemid 350135573)
10. Laoukili J, Stahl M and Medema RH: FoxM1: at the crossroads of ageing and cancer. Biochim Biophys Acta 1775: 92-102, 2007.
11. Ye H, Holterman AX, Yoo KW, Franks RR and Costa RH: Premature expression of the winged helix transcription factor HFH-11B in regenerating mouse liver accelerates hepatocyte entry into S phase. Mol Cell Biol 19: 8570-8580, 1999. (Pubitemid 30414050)
12. Teh MT, Wong ST, Neill GW, Ghali LR, Philpott MP and Quinn AG: FOXM1 is a downstream target of Gli1 in basal cell carcinomas. Cancer Res 62: 4773-4480, 2002.
13. Liu M, Dai B, Kang SH, et al: FoxM1B is overexpressed in human glioblastomas and critically regulates the tumorigenicity of glioma cells. Cancer Res 66: 3593-3602, 2006.
14. Chan DW, Yu SY, Chiu PM, et al: Over-expression of FOXM1 transcription factor is associated with cervical cancer progression and pathogenesis. J Pathol 215: 245-252, 2008. (Pubitemid 351956705)
15. Zhang Y, Zhang N, Dai B, et al: FoxM1B transcriptionally regulates vascular endothelial growth factor expression and promotes the angiogenesis and growth of glioma cells. Cancer Res 68: 8733-8742, 2008.
16. Yang DK, Son CH, Lee SK, Choi PJ, Lee KE and Roh MS: Forkhead box M1 expression in pulmonary squamous cell carcinoma: correlation with clinicopatholocial features and its prognostic significance. Human Pathol 40: 464-470, 2009.
17. Zeng J, Wang L, Li Q, et al: FoxM1 is up-regulated in gastric cancer and its inhibition leads to cellular senescence, partially dependent on p27kipl. J Pathol 218: 419-427, 2009.
18. Calvisi DF, Pinna F, Ladu S, et al: Forkhead box M1B is a determinant of rat susceptibility to hepatocarcinogenesis and sustains ERK activity in human HCC. Gut 58: 679-687, 2009.
19. Li Q Zhang N, Jia Z, et al: Critical role and regulation of transcription factor FoxM1 in human gastric cancer angiogenesis and progression. Cancer Res 69: 3501-3509, 2009.
20. Hamilton SR and Aaltonen LA: Pathology and genetics of tumors of the digestive system. In: World Health Organization Classification of Tumors. Kleihues P and Sobin LH (eds). International Agency for Research on Cancer. IARC Press, Lyon, pp159-172, 2000.
21. D'Angelica M and Fong Y: The liver. In: Sabiston Textbook of Surgery: The Biological Basis of Modern Surgical Practice. 18th edition. Townsend CM, Meauchamp RD, Evers BM and Mattox KL (eds). Saunders, An Imprint of Elsevier, Philadelphia, PA, pp1463-1523, 2008.
22. American Joint Committee on Cancer (AJCC): Liver. In: AJCC Cancer Staging Manual 6th Edition. Greene FL, Page DL, Fleming ID, et al (eds). Springer-Verlag New York, Inc., New York, NY, pp131-136, 2002.
23. Sun HC, Qiu ZJ, Liu J, et al: Expression of hypoxia-inducible factor-1 alpha and associated proteins in pancreatic ductal adenocarcinoma and their impact on prognosis. Int J Oncol 30: 1359-1368, 2007.
24. Kalin TV, Wang IC, Ackerson TJ, et al: Increased levels of the FoxM1 transcription factor accelerate development and progression of prostate carcinoma in both TRAMP and LADY transgenic mice. Cancer Res 66: 1712-1720, 2006. (Pubitemid 43259956)
25. Kim IM, Ackerson T, Ramakrishna S, et al: The Forkhead Box m1 transcription factor stimulates the proliferation of tumor cells during development of lung cancer. Cancer Res 66: 2153-2161, 2006.
26. Ma RY, Tong TH, Cheung AM, Tsang AC, Leung WY and Yao KM: Raf/MEK/MAPK signaling stimulates the nuclear translocation and transactivating activity of FOXM1c. J Cell Sci 118: 795-806, 2005. (Pubitemid 40372587)